Upside, Downside Movers in the Morning
Upside:
-REPL +132% (announces Favorable Outcome of FDA’s Cellular, Tissue, and Gene Therapies Advisory Committee Meeting for RP1 in Advanced Melanoma)
-AXTI +40% (earnings, guidance)
-NWL +20% (earnings, guidance)
-CDNA +13% (earnings, guidance)
-AMZN +11% (earnings, guidance)
-MPWR +11% (earnings, guidance)
-NVT +9.0% (earnings, guidance)
-ETN +7.6% (earnings, guidance)
-DXCM +6.9% (earnings, guidance)
-RYAN +6.8% (earnings, guidance)
-GH +6.3% (earnings, guidance)
-FND +5.7% (earnings, guidance)
-CCJ +5.6% (earnings, guidance)
-MOG.A +5.0% (earnings, guidance)
-MU +4.1% (momentum)
-BB +3.4% (earnings, guidance)
-FSLR +2.6% (earnings, guidance)
Downside:
-BIOA -61% (weakness following NVO investigational drug to treat multiple inflammatory diseases fails to reach key goal)
-GLUE -30% (weakness following NVO investigational drug to treat multiple inflammatory diseases fails to reach key goal)
-RBLX -22% (earnings, guidance)
-MTZ -17% (earnings, guidance)
-GDDY -16% (earnings, guidance)
-ALHC -15% (earnings, guidance)
-PRM -14% (earnings)
-RDDT -14% (earnings, guidance)
-VCYT -11% (earnings, guidance)
-WU -10% (earnings, guidance)
-AAPL -7.6% (earnings, guidance)
-SYK -6.7% (earnings, guidance)
-COIN -6.0% (earnings, guidance)
-JEF -5.7% (assessing exposure to Radiant World amid concerns around Radiant potential falsification of documents)
-TU -5.5% (earnings, guidance)
-AJG -4.4% (earnings)
-AN -4.0% (earnings)
-ABBV -3.6% (earnings, guidance)
-LIN -3.0% (earnings, guidance)
Positions: None.